Cipla
Search results
Our global manufacturing footprint helps us deliver quality pharmaceuticals around the world.
Headquartered in Baltimore, Maryland, Lupin Pharmaceuticals Inc. (LPI), the company's US subsidiary is a $891 million enterprise. It has a presence in the branded and generics markets of the US. In the branded business, Lupin operates in the CVS and Pediatric segments.
Lupin’s commitment to innovation and patient-centricity has fueled its success in therapeutic areas such as cardiovascular health, tuberculosis, diabetes, respiratory, gastrointestinal disorders, and women’s health.
Lupin Limited is a transnational pharmaceutical Company. The Company is engaged in producing a range of generic and branded formulations and bulk drugs. It manufactures Active Pharmaceutical...
4 days ago · Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 71,393.49 Crore) operating in Pharmaceuticals sector. Lupin Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Services, Export Incentives and Other Operating Revenue for the year ending 31-Mar-2023.
Jun 17, 2024 · Lupin, a pharmaceutical company, has launched a new subsidiary named Lupin Manufacturing Solutions (LMS) to enter the Contract Development and Manufacturing Organization (CDMO) business. Abdelaziz Toumi (Abdel), with extensive experience in biotech, pharma, and CDMO sectors across multiple continents, has been appointed as the CEO of LMS.
Jun 22, 2024 · Lupin, a pharmaceutical company, has launched a new subsidiary named Lupin Manufacturing Solutions (LMS) to enter the Contract Development and Manufacturing Organization (CDMO) business. Abdelaziz Toumi (Abdel), with extensive experience in biotech, pharma, and CDMO sectors across multiple continents, has been appointed as the CEO of LMS.
